Muscle regeneration in dystrophic mdx mice is enhanced by isosorbide dinitrate

Neuroscience Letters

Volumn 382, Issue 3, 2005, Pages 342-345

  Marques, Maria Julia ^a   Mendes Luz, Marcus Alexandre ^a   Minatel, Elaine ^a   Neto, Humberto Santo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

DMD; Isosorbide dinitrate; mdx; Muscle regeneration; Nitric oxide

Indexed keywords

BUPIVACAINE; ISOSORBIDE DINITRATE; NITRIC OXIDE DONOR; SODIUM CHLORIDE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DYSTROPHY; MALE; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TIBIALIS ANTERIOR MUSCLE;

ANESTHETICS, LOCAL; ANIMALS; BUPIVACAINE; ISOSORBIDE DINITRATE; MALE; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; NITRIC OXIDE DONORS; REGENERATION;

EID: 19544373466     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.03.023     Document Type: Article

References (28)

1. J.E. Anderson A role for nitric oxide in muscle repair; nitric-oxide mediated satellite cell activation Mol. Biol. Cell 11 2000 1859 1874
2. J.E. Anderson, and C. Vargas Correlated NOS-Iμ and myf5 expression by satellite cells in mdx mouse muscle regeneration during NOS manipulation and deflazacort treatment Neuromuscul. Disord. 13 2003 388 396
3. S. Bogdanovich, K.J. Perkins, T.O.B. Krag, and T.S. Khurana Therapeutics for Duchenne muscular dystrophy: current approaches and future directions J. Mol. Med. 82 2004 102 115
4. R.H. Boger, and S.M. Bode-Boger The clinical pharmacology of l-arginine Ann. Rev. Pharmacol. Toxicol. 41 2001 79 99
5. J.E. Brenman, D.S. Chao, H. Xia, K. Aldape, and D.S. Bredt Nitric oxide synthase is complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy Cell 82 1995 743 745
6. S.B.P. Chargé, and M.A. Rudnicki Cellular and molecular regulation of muscle regeneration Physiol. Rev. 84 2004 209 238
7. G. Cirino, S. Fiorucci, and W.C. Sessa Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol. Sci. 24 2003 91 95
8. G.R. Coulton, J.E. Morgan, T.A. Partridge, and J.C. Sloper The mdx mouse skeletal muscle myopathy. I. A histological, morphometric and biochemical investigation Neuropathol. Appl. Neurobiol. 14 1988 53 70
9. T.M. Dawdson, J.P. Steiner, V.L. Dawson, J.L. Dinerman, G.R. Uhl, and S.H. Snyder Immunosuppressant FK 506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 90 1993 9808 9812
10. A.G. Engel, M. Yamamoto, and K.H. Fishback Muscular dystrophies A.G. Engel C. Franzini-Armstrong Myology vol. 2 1994 McGraw-Hill New York 1133 1187
11. R.W. Evans, J.D. Fernstrom, J. Thompson, S.M. Morris, and L.H. Kuller Biochemical responses of healthy subjects during dietary supplementation with l-arginine J. Nutr. Biochem. 15 2004 534 539
12. H.L. Fung Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annu. Rev. Pharmacol. Toxicol. 33 2004 67 85
13. ®) therapy protects dystrophic skeletal muscle from necrosis FASEB J. 18 2004 676 682
14. J.P. Lefaucheur, C. Pastoret, and A. Sebille Phenotype of dystrophinopathy in old mdx mice Anat. Rec. 242 1995 70 76
15. M.A.M. Luz, M.J. Marques, and H. Santo-Neto Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells Braz. J. Med. Biol. Res. 34 2002 691 695
16. S. Orimo, E. Hiyamuta, K. Arahata, and H. Sugita Analysis of inflammatory cells and complement C3 in bupivacaine-induced myonecrosis Muscle Nerve 14 1991 515 520
17. J.D. Parker, and J.O. Parker Nitrate therapy for stable angina pectoris N. Engl. J. Med. 338 1998 520 531
18. D.E. Reed, J.M. Akester, J.F. Prather, J.R. Tuckosh, D.H. McCurdy, and C. Yeh Blood and tissue level of [14 C] isosorbide dinitrate after oral and intravenous administration to rat Pharmacol. Exp. Ther. 202 1977 32 37
19. K. Sakuma, J. Nishikawa, R. Nakao, K. Watanabe, T. Totsuka, H. Nakano, M. Sano, and M. Yasuhara Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2 Acta Neuropathol. 105 2003 271 280
20. S.M. Sheehan, R. Tatsumi, C.J. Temm-Grove, and R.E. Allen HGF is an autocrine growth factor for skeletal muscle satellite cells in vitro Muscle Nerve 23 2000 239 245
21. H.H. Stedman, H.L. Sweeney, J.B. Shrager, and H.C. Maguire The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy Nature 352 1991 536 539
22. A. Stockis, S. De Bruyn, X. Deroubaix, B. Jeanbaptiste, E. Lebacq, F. Nollevaux, G. Poli, and D. Acerbi Pharmacokinetic profile of new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multilab R) Eur. J. Pharmacol. Biophys. 53 2002 49 56
23. N. Stupka, P. Gregorevic, D.R. Plant, and G.S. Lynch The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice Acta Neuropathol. 104 2004 299 310
24. R. Tatsumi, A. Hattori, Y. Ikeuchi, J.E. Anderson, and R.E. Allen Release of hepatocyte growth factor from mechanically stretched skeletal muscles satellite cells and role of pH and nitric oxide Mol. Biol. Cell 13 2002 2909 2918
25. J.G. Tidball, and M. Wehling-Henricks Evolving therapeutics strategies for Duchenne muscular dystrophy: targeting downstream events Pediatr. Res. 56 2004 831 841
26. ®) in patients with angina Adv. Ther. 16 1999 263 271
27. T.B. Vree, E. Dammers, and R. Valducci Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different prolonged release formulations Int. J. Clin. Pharm. Therap. 42 2004 463 472
28. M. Wehling, M.J. Spencer, and J.G. Tidball A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice J. Cell Biol. 155 2001 123 131